Provided by Tiger Trade Technology Pte. Ltd.

Femasys Inc

0.5574
-0.0213-3.68%
Post-market: 0.57400.0166+2.98%19:57 EDT
Volume:744.92K
Turnover:417.70K
Market Cap:33.17M
PE:-0.81
High:0.5899
Open:0.5821
Low:0.5500
Close:0.5787
52wk High:1.70
52wk Low:0.3067
Shares:59.50M
Float Shares:49.76M
Volume Ratio:1.51
T/O Rate:1.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6900
EPS(LYR):-0.8450
ROE:-376.23%
ROA:-69.37%
PB:7.28
PE(LYR):-0.66

Loading ...

Femasys Inc. Q3 EPS USD -0.1

THOMSON REUTERS
·
Nov 15, 2025

Press Release: Femasys Announces Third Quarter Financial Results for 2025

Dow Jones
·
Nov 15, 2025

Femasys advances global growth with second partner order for FemBloc in Europe

TIPRANKS
·
Nov 10, 2025

Femasys Secures $500,000 Order for FemBloc Launch in France and Benelux

Reuters
·
Nov 10, 2025

Femasys Advances Global Growth with Second Partner Order for FemBloc® in Europe

GlobeNewswire
·
Nov 10, 2025

Femasys Secures $12 Million Through Private Placement

TIPRANKS
·
Nov 08, 2025

Femasys Inc. Announces Private Placement of Convertible Notes and Warrants

Reuters
·
Nov 08, 2025

Femasys Secures FDA IDE Approval to Advance Final FemBloc Trial Phase

Reuters
·
Nov 03, 2025

Femasys Inc: Agreement to Issue $12 Mln Principal Amount of Senior Secured Convertible Notes, Warrants to Purchase Shares of Common Stock for $58 Mln

THOMSON REUTERS
·
Nov 03, 2025

Femasys Secures FDA Approval to Advance Final Fembloc® Trial Phase and $12 Million Financing, With Potential to Reach $58 Million

THOMSON REUTERS
·
Nov 03, 2025

Femasys: to Use $12 Mln Notes Proceeds to Refinance Existing Debt, Advance Commercialization of Co's' Fertility and Permanent Birth Control Portfolio

THOMSON REUTERS
·
Nov 03, 2025

Femasys Inc: Also Entered Into Definitive Agreement With Certain Institutional & Accredited Investors, Led by Existing Investor Jorey Chernett

THOMSON REUTERS
·
Nov 03, 2025

Femasys, Inc. Advances Non-Surgical Birth Control with FemBloc Study

TIPRANKS
·
Oct 28, 2025

Femasys Launches Post-Market Study for FemBloc Birth Control in Europe

Reuters
·
Oct 22, 2025

Femasys Meets Nasdaq Equity Requirement After Offering

TIPRANKS
·
Oct 21, 2025

Femasys Inc. Receives Nasdaq Notice for Listing Rule Noncompliance

Reuters
·
Oct 21, 2025

Femasys COO Daniel Currie Announces Retirement

Reuters
·
Oct 18, 2025

Femasys jumps with Trump expected to expand IVF access

TIPRANKS
·
Oct 17, 2025

Femasys Inc. to Showcase Fertility Solutions at ASRM Scientific Congress & Expo

Reuters
·
Oct 16, 2025

Femasys announces partnership with Kebomend to commercialize FemBloc

TIPRANKS
·
Sep 25, 2025